Efficacy of lactobacillus rhamnosus GR-1 and of lactobacillus reuteri RC-14 in the treatment and prevention of vaginoses and bacterial vaginitis relapses;Efficacia del lactobacillus rhamnosus GR-1 e del lactobacillus reuteri RC-14 nel trattamento e nella prevenzione delle recidive nelle vaginosi e nelle vaginiti batteriche

Minerva Ginecologica

Volumn 60, Issue 5, 2008, Pages 369-376

  Cianci, A ^a   Giordano, R ^a   Delia, A ^b   Grasso, E ^c   Amodeo, A ^c   De Leo, V ^b   Caccamo, F ^c  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Bacterial adhesion; Lactobacillus rbamnosus; Vaginosis, bacterial, therapy

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CIPROFLOXACIN; DICOFLOR ELLE; FLUCONAZOLE; METRONIDAZOLE; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HUMAN; INFECTION CONTROL; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; RELAPSE; VAGINA SECRETION; VAGINITIS;

ADOLESCENT; ADULT; FEMALE; HUMANS; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MIDDLE AGED; PROBIOTICS; RECURRENCE; VAGINAL DISEASES; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 56849111189     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Donder GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 2002:109:34-43.
2. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol 2001;32:37-41.
3. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum Rc-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healty women. FEMS Immunol Med Microbiol 2003;35:131-4.
4. Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, Reid G. Clinical Study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect 2006;8:2772-6.
5. McLean NW, Rosenstein U. Characterization and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. J Med Microbiol 2000;49:543-52.
6. Kaewsrichan J, Peeyananjarassri K, Kongprasertkit J. Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens. FEMS Immunol Med Microbiol 2006;48:75-83.
7. Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a rewiew. J Antimicrob Chemother 2006;58:266-72.
8. Donder GG. Definition and clasiification of abnormal vaginal flora. Best Pract Res Clin Obstet Gynaecol 2007;21:355-73.
9. Eriksson K, Carlsson B, Forsum U, Larsson PG. A double treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamicyn ovules. Acta Derm Venerol 2005;85:42-6.
10. Donders GG, Bosmans E, Dekeersmaecker A, Vereecken A, Van Buick B, Spitz B. Pathogenesis of abnormal vaginal bacterial flora. Am J Obstet Gynecol 2000;182:872-8.
11. Eschenbach DA, Thwin SS, Patton DL, Hooton TM, Stapleton AE, Agnew K et al. Influence of normal menstrual cycle on vaginal tissue, discharge and microflora. Clin Infect Dis 2000;30:901-7.
12. Young G et al. Interactions of oral strains of Candida Albicans and Lactobacilli. J Bacteriol 1956;75:525-9.
13. Reid G et al. Vaginal lactobacilli inhibiting growth of Garderenella vaginalis , Mobiluncus and other bacterial species cultured from vaginal contento f womwn with bacterial vaginosis. Acta Path Microbiol Immunol Scand Section B 1986;394-403.
14. Osset J, Bartolomé RM, García E, Andreu A. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 2001;183:485-91.
15. Reid G, Burton J, Hammond JA, Bruce AW. Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli. J Med Food 2004;7:223-8.
16. Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce AW et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect 2006;8:1450-4.
17. McLean NW, Rosenstein U. Characterization and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. J Med Microbiol 2000;49:543-52.
18. Strus M, Kucharska A, Kukla G, Brzychczy-WΠoch , Maresz K, Heczko PB. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect Dis Obstet Gynecol 2005;13:69-75.
19. Vogel I, Thorsen P, Curry A, Sandager P, Uldbjerg N. Biomarkers for the prediction of preterm delivery. Acta Obstet Gynecol Scand 2005;84:516-25.